Effect of different doses of parenteral vitamin D3 on serum 25 (OH) D concentrations

Daru

Volumn 17, Issue SUPPL. 1, 2009, Pages 26-29

  Hashemipour, S ^a   Sarukhani, M R ^a   Asef Zadeh, S ^a   Ghazi, A A ^a   Mehrtash, B ^a   Ahmadian Yazdi, M H ^a  

^a QAZVIN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

25(OH) D; Hypervitaminosis d; Vitamin D3

Indexed keywords

25 HYDROXYVITAMIN D; COLECALCIFEROL; PLACEBO;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; HUMAN; INJECTION; MALE; NORMAL HUMAN; RANDOMIZED CONTROLLED TRIAL; TREATMENT DURATION; VITAMIN BLOOD LEVEL; VITAMIN D INTOXICATION;

EID: 75449088427     PISSN: 15608115     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Hosseinpanah, F., Rambod, M., Hossein-Nejad, A., Larijani, B., Azizi, F., Association between vitamin D and bone mineral density in Iranian postmenopausal women , Journal of Bone and Mineral Metabolism, 2008; 26 : 86-92.
2. Hashemipour, S., Larijani, B., Adibi, H., 2. Javadi, E., Sedaghat, M., Pajouhi, M., Soltani, A., Shafaei, A.R., Hamidi, Z., Fard, A.R., Hossein-Nezhad, A., Booya, F. Vitamin D deficiency and causative factors in the population of Tehran.BMC Public Health, 2004, 4:38.
3. Tofighi, P., Hossein-Nezhad, A., Sedighi, N., Maghbooli, Z.H., Larijani, B., Vertebral geometry parameters can predict fractures, Iranian Journal of Public Health, 2007; Suppl: 14-23.
4. Hafezi, R., Hossein-nezhad, A., Mirsafa, M., Maghbooli, Z., Saghafi, H., Karimi, F., Larijani, B.,Association between Vitamin D Deficiency and Unexplained Musculoskeletal Pain, Iranian Journal of Public Health, 2008; Suppl. 49-54.
5. Maghbooli, Z., Hossein-Nezhad, A., Shafaei, A.R.,Karimi, F., Madani, F.S., Larijani, B., Vitamin D status in mothers and their newborns in Iran, BMC Pregnancy Childbirth, 2007; 12;7:1.
6. Whyte, M.P., Haddad, J.G., Walters, D.D., Stamp, T.C. Vitamin D bioavailability: serum 25 hydroxy vitamin D levels in man after oral, subcutaneous, intramuscular, and intravenous vitamin D administration. JCEM ,1979; 48: 906-911
7. Diamond, T.H., Ho, K.W., Rohl, P.G., Meerkin, M. Annual intramuscular injection of a megadose of cholecalciferol for treatment of vitamin D deficiency: efficacy and safety data. Med J Aust, 2005; 183: 10-12.
8. Heikinheimo, R.J., Haavisto, M.V., Harju, E.J., 8. Inkovaara, J.A., Kaarela, R.H., Kolho, L.A., Rajala, S.A. Serum vitamin D level after an annual intramuscular injection of ergocalciferol. Calcif Tissue int,1991; 49: S87.
9. Stephens, W.P., Klimiuk, P.S., Berry, J.L., Mawer, E.B. Annual high-dose vitamin D prophylaxis in Asian immigrants. Lancet, 1981; 2:1199-1202
10. Lips, P. Vitamin D deficiency and secondary hyperparathyroidism in the elderly: consequences for bone loss and fractures and therapeutic implications. Endocrine Rev 2001; 22:477-501.
11. Vieth, 11. R., Chan, P.C., MacFarlane, G.D. Efficacy and safety of vitamin D intake exceeding the lowest observed adverse effect level. Am J Clin Nutr 2001; 73:288-94.
12. Vieth, R. Vitamin D supplementation, 25-hydroxyvitamin D concentrations and safety. Am J Clin Nutr ,1999; 69:842-856.